行情

RDY

RDY

如瑞迪博士
NYSE

实时行情|Nasdaq Last Sale

40.10
-0.10
-0.25%
已收盘, 16:00 12/05 EST
开盘
40.38
昨收
40.20
最高
40.38
最低
39.93
成交量
12.86万
成交额
--
52周最高
42.82
52周最低
34.67
市值
66.47亿
市盈率(TTM)
17.66
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

落后大盘

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

RDY 新闻

  • Dr. Reddy's launches bortezomib for injection in U.S.
  • Seeking Alpha - Article.1天前
  • Dr. Reddy's Laboratories Announces the Launch of Bortezomib for Injection 3.5 mg/vial for Intravenous Use Only in the U.S. Market
  • Business Wire.2天前
  • 聚焦英国大选:约翰逊能否带领英国脱离僵局?
  • 环球外汇网官网.3天前
  • 法财长:美对法关税威胁“不可接受” 欧盟将回击
  • 中国新闻网.3天前

更多

所属板块

制药
-0.13%
制药与医学研究
-0.24%

热门股票

名称
价格
涨跌幅

RDY 简况

Dr. Reddy's Laboratories Limited is a pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. The Global Generics segment includes manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). PSAI segment includes the Company's business of manufacturing and marketing active pharmaceutical ingredients and intermediates (API) or bulk drugs. Proprietary Products segment focuses on the research, development and manufacture of differentiated formulations and new chemical entities. These products fall within the dermatology and neurology therapeutic areas, and are marketed and sold through its subsidiary, Promius Pharma, LLC.
展开

Webull提供Dr.Reddy's Laboratories Ltd (ADR)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。